Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q3

2372.TEDINET S100Q33O
Period2022-04-01 → 2022-12-31
Filed2023-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥13.9bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥11.7bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥3.0bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥2.2bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥2.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥3.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.8bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥1.8bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥32.2bnat 2022-12-31Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥26.1bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥20.4bnat 2022-12-31Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.8bnat 2022-12-31Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥9.9bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥8.3bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥185.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.052022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥147.382021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.362021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥184.942022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥147.062021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio36.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.7%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥104m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥58m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥237m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥996m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31−¥100m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-12-31¥4.1bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.0bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥97m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-12-31−¥70m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-12-31¥776m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥691m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-12-31¥69m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-12-31¥8.1bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥115m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥14.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥13.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥907m
—segment totalsegment profit2022-04-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥953m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥4.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥12m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥142m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥811m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥811m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2021-04-01 → 2021-12-31¥489m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2021-04-01 → 2021-12-31¥486m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥3m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2021-04-01 → 2021-12-31−¥452m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-12-31¥3.8bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-12-31¥3.7bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥50m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-12-31¥435m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-12-31¥1.4bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-12-31¥774m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥589m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-12-31¥233m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-12-31¥6.8bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-12-31¥6.7bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥124m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.1bn
—segment totalrevenue2021-04-01 → 2021-12-31¥12.4bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥11.7bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥767m
—segment totalsegment profit2021-04-01 → 2021-12-31¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥12.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥11.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥811m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥3.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 416
ItemContextValueUnit
Deferred tax assetsPrior1YearInstant174000000JPY
Deferred tax assetsCurrentQuarterInstant192000000JPY
Other ioaPrior1YearInstant178000000JPY
Other ioaCurrentQuarterInstant326000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-6000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-6000000JPY
Investments and other assetsPrior1YearInstant4348000000JPY
Investments and other assetsCurrentQuarterInstant5879000000JPY
Noncurrent assetsPrior1YearInstant13452000000JPY
Noncurrent assetsCurrentQuarterInstant16596000000JPY
AssetsPrior1YearInstant26588000000JPY
AssetsCurrentQuarterInstant32221000000JPY
Accounts payable tradePrior1YearInstant251000000JPY
Accounts payable tradeCurrentQuarterInstant336000000JPY
Short term loans payablePrior1YearInstant3650000000JPY
Short term loans payableCurrentQuarterInstant4900000000JPY
Current portion of long term loans payablePrior1YearInstant1329000000JPY
Current portion of long term loans payableCurrentQuarterInstant1738000000JPY
Income taxes payablePrior1YearInstant356000000JPY
Income taxes payableCurrentQuarterInstant372000000JPY
Contract liabilitiesPrior1YearInstant356000000JPY
Contract liabilitiesCurrentQuarterInstant351000000JPY
Advances receivedPrior1YearInstant86000000JPY
Advances receivedCurrentQuarterInstant79000000JPY
Lease obligations clPrior1YearInstant147000000JPY
Lease obligations clCurrentQuarterInstant142000000JPY
Other clPrior1YearInstant1257000000JPY
Other clCurrentQuarterInstant2051000000JPY
Current liabilitiesPrior1YearInstant7435000000JPY
Current liabilitiesCurrentQuarterInstant9973000000JPY
Long term loans payablePrior1YearInstant7200000000JPY
Long term loans payableCurrentQuarterInstant8658000000JPY
Deferred tax liabilitiesPrior1YearInstant1000000JPY
Deferred tax liabilitiesCurrentQuarterInstant38000000JPY
Asset retirement obligations nclPrior1YearInstant149000000JPY
Asset retirement obligations nclCurrentQuarterInstant150000000JPY
Guarantee deposits received2 nclPrior1YearInstant352000000JPY
Guarantee deposits received2 nclCurrentQuarterInstant390000000JPY
Net defined benefit liabilityPrior1YearInstant172000000JPY
Net defined benefit liabilityCurrentQuarterInstant171000000JPY
Lease obligations nclPrior1YearInstant1067000000JPY
Lease obligations nclCurrentQuarterInstant961000000JPY
Other nclPrior1YearInstant46000000JPY
Other nclCurrentQuarterInstant40000000JPY
Noncurrent liabilitiesPrior1YearInstant8991000000JPY
Noncurrent liabilitiesCurrentQuarterInstant10411000000JPY
LiabilitiesPrior1YearInstant16426000000JPY
LiabilitiesCurrentQuarterInstant20384000000JPY
Capital stockPrior1YearInstant3879000000JPY
Capital stockCurrentQuarterInstant3899000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass